Cherry Thomas
Keine laufenden Positionen mehr
Karriereverlauf von Cherry Thomas
Ehemalige bekannte Positionen von Cherry Thomas
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | 01.03.2022 |
| JOUNCE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| BEIGENE, LTD. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Cherry Thomas
| University of California, Los Angeles | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| University of California, Irvine | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Cayman Islands | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| BEIGENE, LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
- Börse
- Insiders
- Cherry Thomas
- Erfahrung
